Get the Stockscreener App
8.0143
0.44%
-0.0357
After Hours:
8.00
-0.0143
-0.18%
Femto Technologies Inc stock is traded at $8.0143, with a volume of 15,444.
It is down -0.44% in the last 24 hours and down -6.16% over the past month.
Femto Technologies Inc is an integrated software company. It owns and markets "Benefit CRM", a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management.
See More
Previous Close:
$8.05
Open:
$8.05
24h Volume:
15,444
Relative Volume:
0.55
Market Cap:
$5.21M
Revenue:
$797.30K
Net Income/Loss:
$-13.61M
P/E Ratio:
-131.60
EPS:
-0.0609
Net Cash Flow:
$-2.85M
1W Performance:
+0.18%
1M Performance:
-6.16%
6M Performance:
-66.33%
1Y Performance:
-99.75%
1-Day Range:
$8.00
$8.10
1-Week Range:
$7.94
$8.10
52-Week Range:
$7.8285
$4,522.00
Femto Technologies Inc Stock (BCAN) Company Profile
Name
Femto Technologies Inc
Sector
Industry
Phone
-
Address
-
Femto Technologies Inc Stock (BCAN) Latest News
BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) Short Interest Update - Defense World
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16% - MSN
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $11.90 - Defense World
Market Insights: FibroGen Inc (FGEN)’s Notable Drop of -1.78, Closing at 0.41 - The Dwinnex
Investing in Fortress Biotech Inc (FBIO) Is Getting More Attractive - Knox Daily
Cantor Fitzgerald Lowers 4D Molecular Therapeutics (NASDAQ:FDMT) to Neutral - MarketBeat
Is FibroGen Inc (FGEN) a threat to investors? - US Post News
Magnetar Financial LLC Increases Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum Raises £17.5M in Series A Funding - FinSMEs
Femsa stock downgraded as cash-back falls short despite divestments, says JPMorgan - Investing.com Australia
Femsa downgraded to Neutral from Overweight at JPMorgan - TipRanks
Fortune Brands Innovations, Inc. (NYSE:FBIN) is Teca Partners LP's 3rd Largest Position - MarketBeat
Fletcher Building Initiates Trading Halt for Capital Raise - TipRanks
Baupost Group LLC MA Grows Stock Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
4D Molecular Therapeutics Inc [FDMT] Records 200-Day SMA of $22.26 - Knox Daily
First Eagle Investment Management LLC Buys 108,500 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum secures £17.5m in Series A - FinTech Global
Analyzing Ratios: Fomento Economico Mexicano S.A.B. de C.V. ADR (FMX)’s Financial Story Unveiled - The Dwinnex
Fedbank Financial Services allots 1.32 lakh equity shares under ESOS - Business Standard
A new trading data show 4D Molecular Therapeutics Inc (FDMT) is showing positive returns. - SETE News
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh - StreetInsider.com
4D Molecular Therapeutics Inc [FDMT] Revenue clocked in at $21.99 million, down -33.37% YTD: What’s Next? - The DBT News
Ferovinum secures £17.5m for global expansion - The Spirits Business
4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Increased to $39.00 by Analysts at Chardan Capital - Defense World
First Eagle Investment Management LLC Buys 108,500 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat
Ferrum Health Raises $16M in Series A Funding - FinSMEs
Epic Global rebrands as Feenix - Sport for Business
Ferovinum secures £17.5M Series A for wine and spirits platform - Tech.eu
Funding platform Ferovinum raises £17.5m for global expansion, having provided £114m to grow the UK wine and spirits industry - Fintech Alliance
Ferrum Health nabs $16M to get FDA-cleared AI into hospitals - Axios
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate - Yahoo Finance
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 14.4% - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Given New $39.00 Price Target at Chardan Capital - MarketBeat
4D Molecular Therapeutics' (FDMT) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
London-based Ferovinum a funding and supply chain platform for wine and spirits raises over €20.8 million - EU-Startups
FibroGen Inc (FGEN) can make a big difference with a little luck - SETE News
FibroGen Inc (FGEN) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
FDMT Stock: Exploring 4D Molecular Therapeutics Inc’s Growth - The InvestChronicle
(FEM) Investment Analysis - Stock Traders Daily
Texas Permanent School Fund Corp Has $1.55 Million Position in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Bought by Mutual of America Capital Management LLC - MarketBeat
Fabtech Technologies Files for IPO to Fund Expansion - Indiainfoline
Beck Bode LLC Decreases Holdings in Flowserve Co. (NYSE:FLS) - MarketBeat
Stock Radar: Fiem Industries up nearly 30% in 1 month, hits fresh record high in September; buy, sell or h - The Economic Times
4D Molecular Therapeutics (NASDAQ:FDMT) Trading 4.2% Higher - Defense World
FEMSA Stock Declines 20.8% YTD: Is a Recovery on the Horizon? - Yahoo Finance
Femasys Announces Infertility Clinic Customers from Coast to Coast - GlobeNewswire
Fabtech Technologies Files IPO Papers - Indiainfoline
Fletcher Building Reports New Executive Shareholdings - TipRanks
FDMT (4D Molecular Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
Was anything positive for 4D Molecular Therapeutics Inc (FDMT) stock last session? - US Post News
Femto Technologies Inc Stock (BCAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):